Skip to main content

Jeffrey Harold Lawson, MD, PhD

Adjunct Professor in the Department of Surgery
Office: 481 Med Sci Res Bldg, Durham, NC 27710
Campus Mail: DUMC Box 2622 Med Ctr, Durham, NC 27710

The research interests of my laboratory include the study of vascular biology and cellular differentiation of vascular tissue, the proteolytic and cell mediated regulation of blood coagulation, inflammatory mediated thrombosis, and the development of bioengineered blood vessels. The clinical interests of my laboratory include the study of novel therapies for vascular and cardiovascular surgery, thrombosis related to surgical procedures, clinical inhibitors of blood coagulation proteases, and the study of the immune response to biologics used in surgery.

Education and Training

  • Ph.D., University of Vermont, 1992
  • M.D., University of Vermont, 1991

Publications

Gutowski, Piotr, Shawn M. Gage, Malgorzata Guziewicz, Marek Ilzecki, Arkadiusz Kazimierczak, Robert D. Kirkton, Laura E. Niklason, et al. “Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease.” J Vasc Surg, February 21, 2020. https://doi.org/10.1016/j.jvs.2019.11.056.

Full Text

Cline, Brendan C., Shawn M. Gage, James Ronald, Waleska M. Pabon-Ramos, Ellen D. Dillavou, Tony P. Smith, Jeffrey H. Lawson, and Charles Y. Kim. “Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment.” J Vasc Interv Radiol 31, no. 2 (February 2020): 243–50. https://doi.org/10.1016/j.jvir.2019.06.010.

Full Text

Morrison, Jonathan J., John McMahon, Joseph J. DuBose, Thomas M. Scalea, Jeffrey H. Lawson, and Todd E. Rasmussen. “Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care.” J Trauma Acute Care Surg 87, no. 1S Suppl 1 (July 2019): S44–47. https://doi.org/10.1097/TA.0000000000002350.

Full Text

Kirkton, Robert D., Maribel Santiago-Maysonet, Jeffrey H. Lawson, William E. Tente, Shannon L. M. Dahl, Laura E. Niklason, and Heather L. Prichard. “Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.” Sci Transl Med 11, no. 485 (March 27, 2019). https://doi.org/10.1126/scitranslmed.aau6934.

Full Text

Dolmatch, Bart L., John C. Gurley, Kevin M. Baskin, Boris Nikolic, Jeffrey H. Lawson, Surendra Shenoy, Theodore F. Saad, et al. “Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).” J Vasc Access 20, no. 2 (March 2019): 114–22. https://doi.org/10.1177/1129729818791409.

Full Text

Bylsma, Lauren C., Heidi Reichert, Shawn M. Gage, Prabir Roy-Chaudhury, Robert J. Nordyke, Jon Fryzek, Shannon L. M. Dahl, Theodore Lithgow, and Jeffrey H. Lawson. “Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.” Am J Nephrol 49, no. 2 (2019): 156–64. https://doi.org/10.1159/000495355.

Full Text

Kirkton, R. D., M. Santiago-Maysonet, J. H. Lawson, W. E. Tente, S. L. M. Dahl, L. E. Niklason, and H. L. Prichard. “Erratum: Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation (Science Translational Medicine DOI: 10.1126/scitranslmed.aau6934).” Science Translational Medicine 11, no. 490 (January 1, 2019). https://doi.org/10.1126/scitranslmed.aax7791.

Full Text

Lawson, Jeffrey H., Shannon L. Dahl, Shawn M. Gage, Alison J. Pilgrim, Heather L. Prichard, William E. Tente, and Laura E. Niklason. “Engineering Human Acellular Vessels for Dialysis Access and Vascular Repair.” In Journal of the American College of Surgeons, 227:e67–68. Elsevier BV, 2018. https://doi.org/10.1016/j.jamcollsurg.2018.08.166.

Full Text

Trerotola, Scott O., Jeffrey Lawson, Prabir Roy-Chaudhury, Theodore F. Saad, and Theodore F. Lutonix AV Clinical Trial Investigators. “Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial.” Clin J Am Soc Nephrol 13, no. 8 (August 7, 2018): 1215–24. https://doi.org/10.2215/CJN.14231217.

Full Text

Dolmatch, Bart L., John C. Gurley, Kevin M. Baskin, Boris Nikolic, Jeffrey H. Lawson, Surendra Shenoy, Theodore F. Saad, et al. “Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).” J Vasc Interv Radiol 29, no. 4 (April 2018): 454-460.e3. https://doi.org/10.1016/j.jvir.2017.12.013.

Full Text

Pages